NCT04713878View on ClinicalTrials.gov

Mesenchymal Stem Cells Therapy in Patients With COVID-19 Pneumonia

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

May 8, 2020

Primary Completion Date

June 30, 2020

Study Completion Date

July 15, 2020

Conditions
Coronavirus Disease 2019 (COVID-19) Pneumonia
Interventions
OTHER

Mesenchymal stem cells

Intravenous infusion of Mesenchymal stem cells

Trial Locations (1)

Unknown

University of Health Sciences, Istanbul

All Listed Sponsors
lead

Kanuni Sultan Suleyman Training and Research Hospital

OTHER

NCT04713878 - Mesenchymal Stem Cells Therapy in Patients With COVID-19 Pneumonia | Biotech Hunter | Biotech Hunter